Application 201967

Related Records

Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	RIZATRIPTAN BENZOATE	RIZATRIPTAN BENZOATE	TABLET;ORAL	EQ 5MG BASE	No	No
002	RIZATRIPTAN BENZOATE	RIZATRIPTAN BENZOATE	TABLET;ORAL	EQ 10MG BASE	No	No

NDC	Name	Nonproprietary name	Labeler	Marketing category	Status
50090-2069	rizatriptan benzoate	rizatriptan benzoate	A-S Medication Solutions	ANDA	Current
68462-465	rizatriptan benzoate	rizatriptan benzoate	Glenmark Pharmaceuticals Inc., USA	ANDA	Current
68462-465	rizatriptan benzoate	rizatriptan benzoate	Glenmark Pharmaceuticals Inc., USA	ANDA	Current
68462-465	rizatriptan benzoate	rizatriptan benzoate	Glenmark Pharmaceuticals Inc., USA	ANDA	Current
68462-465	rizatriptan benzoate	rizatriptan benzoate	Glenmark Pharmaceuticals Inc., USA	ANDA	Current
68462-465	rizatriptan benzoate	rizatriptan benzoate	Glenmark Pharmaceuticals Inc., USA	ANDA	Current
68462-466	rizatriptan benzoate	rizatriptan benzoate	Glenmark Pharmaceuticals Inc., USA	ANDA	Current
68462-466	rizatriptan benzoate	rizatriptan benzoate	Glenmark Pharmaceuticals Inc., USA	ANDA	Current
68462-466	rizatriptan benzoate	rizatriptan benzoate	Glenmark Pharmaceuticals Inc., USA	ANDA	Current
68462-466	rizatriptan benzoate	rizatriptan benzoate	Glenmark Pharmaceuticals Inc., USA	ANDA	Current
68462-466	rizatriptan benzoate	rizatriptan benzoate	Glenmark Pharmaceuticals Inc., USA	ANDA	Current